https://www.law360.com/health/articles/4632/sec-s-healthsouth-complaint-thrashed-by-judge?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T03:57:13Z monthly 0.5 https://www.law360.com/health/articles/4635/acacia-takes-aim-at-hospitals-with-new-patent-portfolio?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T06:30:25Z monthly 0.5 https://www.law360.com/health/articles/4624/preliminary-injunction-forces-medical-device-off-shelves?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T21:48:40Z monthly 0.5 https://www.law360.com/health/articles/4619/teva-sandoz-launch-at-risk-versions-of-pfizer-drug?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T15:20:00Z monthly 0.5 https://www.law360.com/health/articles/4617/pfizer-wins-lipitor-patent-challenge?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T10:17:42Z monthly 0.5 https://www.law360.com/health/articles/4606/suit-challenges-uspto-decision-on-biotech-dispute-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T06:17:11Z monthly 0.5 https://www.law360.com/health/articles/4581/injunction-upheld-in-applera-v-mj-research-patent-fight?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T23:41:56Z monthly 0.5 https://www.law360.com/health/articles/4571/federal-circuit-upholds-injunction-vs-teva-ranbaxy?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T22:36:14Z monthly 0.5 https://www.law360.com/health/articles/4564/mylan-failed-to-prove-identical-ingredients-abbott-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T19:31:55Z monthly 0.5 https://www.law360.com/health/articles/4566/ulcer-drug-patents-spark-court-battle?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T19:49:55Z monthly 0.5 https://www.law360.com/health/articles/4554/dna-replication-suit-favors-invitrogen-in-federal-circuit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T15:19:59Z monthly 0.5 https://www.law360.com/health/articles/4540/patent-victory-propels-corning-s-life-sciences-expansion?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T14:52:45Z monthly 0.5 https://www.law360.com/health/articles/4519/group-urges-investigation-of-other-frist-stock-sales?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T02:13:27Z monthly 0.5 https://www.law360.com/health/articles/4510/roche-gilead-reach-tamiflu-agreement?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T18:38:57Z monthly 0.5 https://www.law360.com/health/articles/4518/j-j-faces-new-challenge-to-schizophrenia-drug?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T19:53:38Z monthly 0.5 https://www.law360.com/health/articles/4504/j-j-guidant-merger-spotlights-stent-patent-wars?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T22:00:15Z monthly 0.5 https://www.law360.com/health/articles/4492/drug-store-giants-challenged-over-generic-packaging?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T12:58:45Z monthly 0.5 https://www.law360.com/health/articles/4486/sanofi-aventis-must-allow-news-site-to-use-drug-name?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T05:05:26Z monthly 0.5 https://www.law360.com/health/articles/4475/impax-opens-new-front-in-adderall-battle-with-shire?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T11:21:50Z monthly 0.5 https://www.law360.com/health/articles/4474/judge-bans-andrx-ranbaxy-generic-versions-of-biaxin?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T09:28:19Z monthly 0.5 https://www.law360.com/health/articles/4464/israel-revamps-drug-patent-extension-policy?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T19:22:23Z monthly 0.5 https://www.law360.com/health/articles/4463/hospital-chain-slapped-with-class-action-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T19:26:28Z monthly 0.5 https://www.law360.com/health/articles/4452/astrazeneca-sues-teva-over-seroquel-patent-challenge?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T23:43:53Z monthly 0.5 https://www.law360.com/health/articles/4458/amgen-sues-roche-over-anemia-treatment?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T01:21:38Z monthly 0.5 https://www.law360.com/health/articles/4438/healthcare-exec-settles-117-m-fraud-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T14:40:05Z monthly 0.5 https://www.law360.com/health/articles/4440/ftc-lawsuit-sends-barr-back-to-court?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T07:44:50Z monthly 0.5 https://www.law360.com/health/articles/4428/authorized-generics-deal-cleared-of-antitrust-charges?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T16:58:19Z monthly 0.5 https://www.law360.com/health/articles/4435/charges-mount-against-guidant-as-j-j-deal-sours?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T00:20:48Z monthly 0.5 https://www.law360.com/health/articles/4436/in-a-twist-generics-maker-says-pfizer-infringed-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T23:48:21Z monthly 0.5 https://www.law360.com/health/articles/4420/imclone-stockholders-settle-insider-trading-charges?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T04:34:41Z monthly 0.5 https://www.law360.com/health/articles/4421/pfizer-and-mylan-back-to-court-in-lengthy-dispute?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T17:54:05Z monthly 0.5 https://www.law360.com/health/articles/4419/supreme-court-may-co-opt-patent-reform?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T14:34:28Z monthly 0.5 https://www.law360.com/health/articles/4404/chief-justice-drops-out-of-landmark-patent-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-10T01:24:53Z monthly 0.5 https://www.law360.com/health/articles/4405/drug-makers-gear-up-for-round-two-in-lipitor-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T12:02:56Z monthly 0.5 https://www.law360.com/health/articles/4400/supreme-court-mulls-case-on-authorized-generics?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-08T19:24:24Z monthly 0.5 https://www.law360.com/health/articles/4393/novartis-purchase-of-chiron-puts-spotlight-on-biologics?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-07-09T02:05:21Z monthly 0.5